Vaccines, human use in   China

Exports In 2022, China exported $1.2B in Vaccines, human use, making it the 11th largest exporter of Vaccines, human use in the world. At the same year, Vaccines, human use was the 530th most exported product in China. The main destination of Vaccines, human use exports from China are: Brazil ($123M), Bangladesh ($114M), United Arab Emirates ($85.1M), Indonesia ($79.9M), and Burma ($61.4M).

The fastest growing export markets for Vaccines, human use of China between 2021 and 2022 were Angola ($43.7M), Venezuela ($27.5M), and Ethiopia ($20.1M).

Imports In 2022, China imported $2.92B in Vaccines, human use, becoming the 6th largest importer of Vaccines, human use in the world. At the same year, Vaccines, human use was the 103rd most imported product in China. China imports Vaccines, human use primarily from: Ireland ($2.03B), France ($339M), Belgium ($190M), Brazil ($151M), and United States ($134M).

The fastest growing import markets in Vaccines, human use for China between 2021 and 2022 were Ireland ($1.47B), Brazil ($151M), and United States ($47.5M).

COMPANIES In 2023, leading companies such as IKEA SUPPLY AG (3.6M), WAL-MART INC. (2.68M), and AMAZON SERVICES LLC (1.42M) were at the forefront of shipping Vaccines, human use from China to the United States.